checkmate 274 & ev-301: highlights in uc from asco gu
Published 3 years ago • 176 plays • Length 4:22Download video MP4
Download video MP3
Similar videos
-
5:40
highlights in bladder cancer from asco gu 2021
-
2:06
checkmate 274: nivolumab versus placebo in high-risk urothelial cancer
-
1:35
checkmate 274: adjuvant nivolumab versus placebo for urothelial carcinoma
-
9:24
key updates in bladder cancer from asco gu 2021
-
0:50
asco gu 2021 highlights: enfortumab vedotin, oral docetaxel and 177lu-psma-617
-
4:35
highlights from asco gu 2022
-
46:21
latest insights: when to choose orbital atherectomy - europcr 2021
-
2:44
introducing gi genius™ intelligent endoscopy module
-
2:53
matthew galsky, md, elaborates on outcomes from the checkmate 274 trial
-
12:58
treatment of advanced urothelial carcinoma – a discussion of ev-301
-
6:01
ev-201, ev-301 and unite: enfortumab vedotin in advanced urothelial cancer
-
5:21
jorge a. garcia, md, summarizes the significance of checkmate 9er from asco gu 2021
-
4:16
unite: enfortumab vedotin in advanced urothelial cancer
-
1:09
x-acto prosharp electric pencil sharpener
-
10:25
asco gu 2022 - janssen highlights niraparib combo data
-
0:15
trust us, we're engineers - hydrate-anator
-
5:40
#07_advanced operation 04
-
11:30
asco 2021 lung recap: surgical outcomes & checkmate 816: nivolumab in early stage nsclc